MAIA
MAIA Biotechnology Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.53
-0.04 ▼ -2.55%
🌙 3월 13일 7:58 PM ET (한국 3/14 08:58)
$1.53
+0.00 -0.03%
| Index | - | P/E | - | EPS (ttm) | -0.74 | Insider Own | 23.64% | Shs Outstand | 0.03B | Perf Week | -0.65% |
| Market Cap | 0.06B | Forward P/E | - | EPS next Y | 6.76% | Insider Trans | 4.55% | Shs Float | 0.03B | Perf Month | -13.56% |
| Enterprise Value | 0.05B | PEG | - | EPS next Q | -0.13 | Inst Own | 6.51% | Short Float | 8.34% | Perf Quarter | 10.87% |
| Income | -0.02B | P/S | - | EPS this Y | 50.17% | Inst Trans | 0.74% | Short Ratio | 2.36 | Perf Half Y | -10% |
| Sales | 0.00B | P/B | 1264.46 | EPS next 5Y | - | ROA | -212.5% | Short Interest | 2.46M | Perf YTD | - |
| Book/sh | 0 | P/C | 5.43 | EPS past 3/5Y | 3.77% -11.4% | ROE | -2691.06% | 52W High | -52.04% ($3.19) | Perf Year | -3.16% |
| Cash/sh | 0.28 | P/FCF | - | Sales past 3/5Y | - | ROIC | -53610.15% | 52W Low | 75.86% ($0.87) | Perf 3Y | -59.63% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 44.5% | Gross Margin | - | Volatility(W/M) | 7.46% 9.61% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.2 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.18 | EPS Q/Q | -134.24% | Profit Margin | - | RSI (14) | 39.01 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.18 | Sales Q/Q | - | SMA20 | -18.05% ($1.87) | Beta | 0.17 | Target Price | $14 |
| Payout | - | Debt/Eq | 0 | Earnings | 2025/11/04 | SMA50 | -20.91% ($1.93) | Rel Volume | 0.63 | Prev Close | $1.57 |
| Employees | 13 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -5.55% ($1.62) | Avg Volume(3M) | 1.04M | Price | $1.53 |
| IPO | 2022/7/28 | Option/Short | No/Yes | Trades | 1727 | Volume | 662,151 | Change | -2.55% |
뉴스 로딩 중...